The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20080802: Mason Wells Buyout Fund II, Limited Partnership; Coating Excellence International, LLC
Cyberheat, Inc., et al., US vs
In the Matter of Realcomp II Ltd. - Sunshine Act Meeting Notice
Equitable Resources, Inc., et al.
0803002 Informal Interpretation
0802011 Informal Interpretation
0802012 Informal Interpretation
0802013 Informal Interpretation
0802014 Informal Interpretation
0802015 Informal Interpretation
0802016 Informal Interpretation
0803001 Informal Interpretation
20080806: Oak Hill Capital Partners III, L.P.; Oak Hill Capital Partners II, L.P.
20080792: Sanmar Holdings Limited; ING Furman Selz Investors III L.P.
20080791: Shimano American Corporation; Nautilus, Inc.
20080782: Ares Corporate Opportunities Fund, L.P.; Hanger Orthopedic Group, Inc.
20080767: Banco de Sabadell, S.A.; Banco Bilbao Vizcaya Argentaria, S.A.
Equitable Resources, Inc., Dominion Resources, Inc., Consolidated Natural Gas Company, and The Peoples Natural Gas Company
The Commission charged that Schering-Plough’s proposed $14.4 billion acquisition of Organon Biosciences N.V. threatened to substantially reduce competition in the U.S. market for three popular vaccines used to treat poultry, a staple in American food markets. The November 2007 order settling the charges required the sale of assets required to develop, manufacture, and market these vaccines to Wyeth. In addition, Schering-Plough was required to sign a supply and transition services agreement with Wyeth, under which Schering will provide the vaccines for a period of two years, allowing time for the necessary FDA approvals.